Loading…

P1.01-056 Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis

Saved in:

Bibliographic Details
Published in:	Journal of thoracic oncology 2017-11, Vol.12 (11), p.S1916-S1916
Main Authors:	Ionova, T., Arzumanyan, A., Bolotina, L., Breder, V., Buevich, N., Danilova, A., Filippova, E., Kornietskaya, A., Kramchaninov, M., Kushniruk, E., Latipova, D., Lipatova, D., Malova, O., Moiseenko, F., Nikitina, T., Orlov, S., Orlova, R., Protsenko, S., Sarantseva, K., Stroyakovsky, D., Zinkovskaya, A., Laktionov, K.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!